Cefadroxil — ein neues Oralcephalosporin mit verlängerter Bioverfügbarkeit F. -U. Bauer Übersicht Pages: S526 - S528
Bakteriologische In-vitro-Untersuchungen mit Cefadroxil Korrelation von Hemmhofdurchmesser und minimaler Hemmkonzentration H. Grimm Mikrobiologie Pages: S529 - S531
Cefadroxil, a new broad-spectrum cephalosporin R. E. BuckK. E. Price Mikrobiologie Pages: S532 - S537
Laboratory studies with BL-S 578 (Cefadroxil) a new broad-spectrum orally active cephalosporin S. RipaM. Prenna Mikrobiologie Pages: S538 - S541
Bactericidal activity of cefadroxil, cephalexin and cephradine in an in vitro pharmacokinetic model F. LeitnerR. A. GoodhinesK. E. Price Mikrobiologie Pages: S542 - S548
Cefadroxil — a new antibiotic with low toxicity potential T. E. HickeyJ. A. BottaA. J. Clemento Toxikologie Pages: S549 - S553
Vergleichende Pharmakokinetik oraler Cephalosporine: Cephalexin, Cefaclor und Cefadroxil H. LodeR. StahlmannP. Koeppe Pharmakokinetik Pages: S554 - S559
Comparative human oral clinical pharmacology of cefadroxil, cephalexin, and cephradine M. PfefferA. JacksonJ. Perche de Menezes Pharmakokinetik Pages: S560 - S566
Vergleichende Untersuchungen zur Pharmakokinetik von Cefadroxil und Amoxicillin nach oraler Nüchterngabe D. AdamP. Gierschik Pharmakokinetik Pages: S567 - S572
Untersuchungen zur Pharmakokinetik von Cefadroxil im Kindesalter A. WindorferK. AlterthumP. Bauer Pharmakokinetik Pages: S573 - S576
Clinical pharmacology of cefadroxil in infants and children Ch. M. GinsburgG. H. McCracken Jr.M. L. Thomas Pharmakokinetik Pages: S577 - S579
Untersuchungen zur Diffusion von Cefadroxil und Cephalexin in das Tonsillengewebe D. Adam Pharmakokinetik Pages: S580 - S583
Zur Pharmakokinetik von Cefadroxil, einem neuen Oralcephalosporin C. Simon Pharmakokinetik Pages: S584 - S587
Comparison of pharmacological and antimicrobial properties of cefadroxil and cephalexin A. I. HartsteinK. E. PatrickR. E. Bryant Pharmakokinetik Pages: S588 - S591
Cefadroxil kinetics in patients with renal insufficiency R. E. CutlerA. D. BlairM. R. Kelly Pharmakokinetik Pages: S592 - S597
Pharmacokinetics of cefadroxil in normal subjects and in patients with renal insufficiency G. HumbertA. LeroyM. Godin Pharmakokinetik Pages: S598 - S602
An overview of results of world-wide clinical trials with cefadroxil P. J. SantellaB. TanriseverE. Berman Klinik Pages: S603 - S609
Cefadroxil bei Infektionen der oberen Atemwege in der Pädiatrie A. WindorferH. Maier-LenzK. Alterthum Klinik Pages: S610 - S613
Clinical evaluation of cefadroxil: A multicenter trial I. Acute lower respiratory tract infections J. HendrickxI. TrimpeneersP. Baert Klinik Pages: S614 - S616
Clinical evaluation of cefadroxil: A multicenter trial. II. Urinary tract infections J. ReynaertJ. VandepitteTh. Hallynck Klinik Pages: S617 - S622
Clinical evaluation of cefadroxil: A multicenter trial III. Miscellaneous infections J. PijckA. VuyeM. Castro Klinik Pages: S623 - S625
Untersuchungen zur Einmaldosierung von Cefadroxil bei Harnwegs-infektionen K. Hochberg Klinik Pages: S626 - S628
Clinical comparison of cefadroxil and cephalexin in uncomplicated urinary tract infection D. M. HennessD. Richards Klinik Pages: S629 - S632
Effective once- or twice-daily treatment of skin and skin structure infections with a new cephalosporin (cefadroxil) D. M. HennessW. E. Gordon Klinik Pages: S633 - S637